Broadening the Perspective of Cost-Effectiveness Modeling in Chronic Obstructive Pulmonary Disease: A New Patient-Level Simulation Model Suitable to Evaluate Stratified Medicine.

Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published Date: Dec 20, 2018

Abstract

OBJECTIVES: To develop a health economic model that included a great diversity of patient characteristics and outcomes for chronic obstructive pulmonary disease (COPD), which can be used to inform decisions about stratified medicine in COPD.

Authors

  • Martine Hoogendoorn
    Institute for Medical Technology Assessment/Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. Electronic address: hoogendoorn@imta.eur.nl.
  • Isaac Corro Ramos
    Institute for Medical Technology Assessment/Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Michael Baldwin
    Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Nuria Gonzalez-Rojas Guix
    Boehringer Ingelheim International GmbH, Ingelheim, Germany.
  • Maureen P M H Rutten-van Mölken
    Institute for Medical Technology Assessment/Erasmus School of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.

Keywords

External Resources

Popular Topics
Recent Journals